Psyched Wellness (TSE:PSYC)
:PSYC
Want to see TSE:PSYC full AI Analyst Report?
Top Page
Psyched Wellness
(PSYC)
Select Model
Select Model
Rating:45Neutral
Price Target:
C$0.02
▼(-25.00% Downside)
Action:Reiterated
Date:06/26/26
The score is held down primarily by weak financial performance: large operating losses, worsening free cash flow burn, and significant equity erosion despite some early revenue traction and no debt. Technicals are mixed with only modest stabilization signals, and valuation is limited by negative earnings and no dividend support.
Positive Factors
Debt-free balance sheet
No reported debt materially reduces interest expense risk and bankruptcy pressure, giving management financial flexibility to prioritize commercialization or strategic investments. For an early-stage consumer-health company this durable strength eases near-term liquidity stress and supports negotiated supplier or partner terms.
Negative Factors
Large operating losses
Net losses that vastly exceed revenues reflect a cost base misaligned with current scale. Persistently deep operating losses erode capital, force strategic trade-offs, and increase dependence on external financing, constraining the firm's ability to invest in marketing, R&D, or distribution without dilution or debt.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
No reported debt materially reduces interest expense risk and bankruptcy pressure, giving management financial flexibility to prioritize commercialization or strategic investments. For an early-stage consumer-health company this durable strength eases near-term liquidity stress and supports negotiated supplier or partner terms.
Read all positive factors
Psyched Wellness (PSYC) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$6.10M
Dividend YieldN/A
Average Volume (3M)81.03K
Price to Earnings (P/E)―
Beta (1Y)-0.41
Revenue Growth-2.34%
EPS Growth-19.25%
CountryCA
Employees1,800
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)-0.02
Shares Outstanding406,715,850
10 Day Avg. Volume36,477
30 Day Avg. Volume81,030
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.86
Price to Sales (P/S)12.22
P/FCF Ratio-1.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Psyched Wellness Business Overview & Revenue Model
Company Description
Psyched Wellness Ltd. operates as a health supplements enterprise, specializing in the production and distribution of artisanal medicinal mushrooms and their associated consumer packaged goods. A prominent offering is their Amanita Muscaria Tinctu...
How the Company Makes Money
Psyched Wellness generates revenue primarily through the sale of its Amanita muscaria–derived consumer wellness products under its own branding, including sales through direct-to-consumer channels (e.g., the company’s website) and through retail/w...
Psyched Wellness Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
42
Neutral
Cash Flow
24
Negative
| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 472.30K | 623.16K | 321.10K | 14.27K | 0.00 |
| Gross Profit | 189.79K | 241.89K | 155.71K | 7.54K | 0.00 |
| EBITDA | -5.08M | -4.52M | -3.32M | -4.29M | -65.14K |
| Net Income | -5.04M | -4.26M | -3.43M | -4.30M | -4.50M |
Balance Sheet | |||||
| Total Assets | 3.75M | 7.89M | 7.34M | 3.31M | 6.38M |
| Cash, Cash Equivalents and Short-Term Investments | 2.25M | 6.36M | 6.13M | 2.57M | 5.53M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 644.82K | 449.33K | 303.56K | 198.07K | 178.15K |
| Stockholders Equity | 3.10M | 7.44M | 7.03M | 3.11M | 6.20M |
Cash Flow | |||||
| Free Cash Flow | -4.05M | -3.11M | -3.11M | -3.18M | -3.04M |
| Operating Cash Flow | -4.05M | -3.10M | -3.03M | -3.09M | -3.01M |
| Investing Cash Flow | 0.00 | -2.78K | -44.84K | 126.99K | -28.58K |
| Financing Cash Flow | 0.00 | 3.39M | 6.64M | 0.00 | 6.51M |
Psyched Wellness Technical Analysis
Positive
0.02
Price Trends
0.01
Positive
0.01
Positive
0.02
Negative
Market Momentum
<0.01
Negative
57.26
Neutral
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:PSYC, the sentiment is Positive. The current price of 0.02 is above the 20-day moving average (MA) of 0.01, above the 50-day MA of 0.01, and above the 200-day MA of 0.02, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 57.26 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:PSYC.
Psyched Wellness Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | C$1.70B | 23.31 | 15.25% | 2.67% | 12.52% | 37.38% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
45 Neutral | C$6.10M | -0.78 | -70.53% | ― | -2.34% | -19.25% | |
45 Neutral | C$924.89K | -0.22 | -190.55% | ― | 3288.96% | 50.66% | |
44 Neutral | C$252.02M | -19.38 | -92.94% | ― | 119.70% | -368.06% |
* Consumer Defensive Sector Average
TSE:PSYC
Psyched Wellness
0.02
-0.02
-50.00%
TSE:BITE
Blender Bites
0.15
0.00
0.00%
TSE:JWEL
Jamieson Wellness Inc
41.02
6.40
18.50%
TSE:HBFG
Happy Belly Food Group
1.70
0.57
50.44%
TSE:MOOO.X
Happy Supplements Inc.
0.35
-0.15
-30.00%
TSE:CULT
Cult Food Science Corp.
0.38
-0.63
-62.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.